Systemic sclerosis (scleroderma) and Haematocrit abnormal

Summary:

Haematocrit abnormal is reported only by a few people with Systemic sclerosis (scleroderma).

The study analyzes which people have Haematocrit abnormal with Systemic sclerosis (scleroderma). It is created by eHealthMe based on 1 person who has Haematocrit abnormal and Systemic sclerosis (scleroderma) from the Food and Drug Administration (FDA), and is updated regularly.

What is Systemic sclerosis (scleroderma)?

Systemic sclerosis (scleroderma) (an autoimmune or connective tissue disease. it is characterized by thickening of the skin) is found to be associated with 495 drugs and 857 conditions by eHealthMe. Check the latest studies of Systemic sclerosis (scleroderma).

What is Haematocrit abnormal?

Haematocrit abnormal is found to be associated with 280 drugs and 595 conditions by eHealthMe. Check the latest studies of Haematocrit abnormal.

On Jul, 21, 2026

1 person who has Systemic Sclerosis (Scleroderma) and Haematocrit Abnormal is studied.

Would you have Haematocrit abnormal when you have Systemic sclerosis (scleroderma)?

Gender of people who have Systemic Sclerosis (Scleroderma) and experienced Haematocrit Abnormal *:

female: 100 %
male: 0.0 %

Age of people who have Systemic Sclerosis (Scleroderma) and experienced Haematocrit Abnormal *:

Common co-existing conditions for these people *:

Pulmonary Hypertension (increase in blood pressure in the lung artery): 1 person, 100.00%

Common drugs taken by these people *:

Ambrisentan: 1 person, 100.00%

Common symptoms for these people *:

Haemoglobin Abnormal: 1 person, 100.00%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Haematocrit abnormal?

- Check whether Haematocrit abnormal is associated with a drug or a condition

Related studies:

How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Haematocrit abnormal and Systemic sclerosis (scleroderma), and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.